Harel Insurance Investments & Financial Services’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-184
Closed -$5K 550
2024
Q2
$5K Sell
184
-86
-32% -$2.49K ﹤0.01% 506
2024
Q1
$8K Sell
270
-7
-3% -$212 ﹤0.01% 503
2023
Q4
$10K Sell
277
-475
-63% -$17.5K ﹤0.01% 542
2023
Q3
$34K Sell
752
-6
-0.8% -$364 ﹤0.01% 502
2023
Q2
$56K Buy
758
+24
+3% +$1.62K ﹤0.01% 469
2023
Q1
$43K Buy
734
+33
+5% +$1.82K ﹤0.01% 506
2022
Q4
$35K Buy
701
+3
+0.4% +$180 ﹤0.01% 529
2022
Q3
$61K Sell
698
-98
-12% -$10.3K ﹤0.01% 473
2022
Q2
$91K Sell
796
-89
-10% -$10.2K ﹤0.01% 420
2022
Q1
$115K Sell
885
-161
-15% -$23.2K ﹤0.01% 437
2021
Q4
$190K Sell
1,046
-1,474
-58% -$256K ﹤0.01% 413
2021
Q3
$374K Sell
2,520
-1,246
-33% -$191K 0.01% 268
2021
Q2
$570K Sell
3,766
-3,774
-50% -$525K 0.01% 427
2021
Q1
$2.13M Buy
+7,540
New +$967K 0.04% 231

Other funds holding OMCL

Harel Insurance Investments & Financial Services's OMCL Position: Q3 2024 in Review

Harel Insurance Investments & Financial Services sold out of Omnicell (OMCL) in Q3 2024, closing a stake of 184 shares — an estimated $5K sold.

Harel Insurance Investments & Financial Services first reported a position in OMCL in Q1 2021 and held it in 14 quarters. The position peaked at $2.13M in Q1 2021. 259 funds tracked by Wall St. Rank hold OMCL as of Q3 2024.

  • Harel Insurance Investments & Financial Services reported no remaining Omnicell position as of Q3 2024 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 184 Omnicell shares in Q3 2024, an estimated $5K.
  • Harel Insurance Investments & Financial Services first reported a position in Omnicell in Q1 2021 and held it in 14 quarters.
  • Harel Insurance Investments & Financial Services's Omnicell position peaked at $2.13M in Q1 2021.
  • 259 funds tracked by Wall St. Rank held Omnicell as of Q3 2024.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2024, filed 15 Oct 2024.